Evaluation of a Web-Based, ‘Purchase Event’ Intensive Monitoring Method for Pharmacovigilance of Natural Health Products: Lessons and Insights from Development Work in New Zealand
Introduction Intensive monitoring methods are used in pharmacovigilance for prescription medicines but have not yet been implemented for natural health products (NHPs). Objectives Our objective was to assess feasibility issues with a new ‘purchase event’ intensive monitoring method for pharmacovigil...
Gespeichert in:
Veröffentlicht in: | Drug safety 2020-10, Vol.43 (10), p.981-998 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 998 |
---|---|
container_issue | 10 |
container_start_page | 981 |
container_title | Drug safety |
container_volume | 43 |
creator | Barnes, Joanne Sheridan, Jane L. Dong, Christine Yang Härmark, Linda Vohra, Sunita Harrison-Woolrych, Mira |
description | Introduction
Intensive monitoring methods are used in pharmacovigilance for prescription medicines but have not yet been implemented for natural health products (NHPs).
Objectives
Our objective was to assess feasibility issues with a new ‘purchase event’ intensive monitoring method for pharmacovigilance of NHPs, including pharmacy and NHP purchaser recruitment rates, collection of NHP purchaser key patient identifier information for data linkage and quality and completeness of data.
Methods
For the Ginkgo study, 213 community pharmacies in the Auckland (Aotearoa New Zealand) District Health Board area were invited to participate. Staff in participating pharmacies (
n
= 3 [1.4%]) recorded ginkgo product sales and gave purchasers a study invitation card (October 2015–January 2016). Ginkgo purchaser participants were emailed links to web-based baseline and follow-up questionnaires about adverse events occurring during/after taking ginkgo. Participating pharmacists and consumers were invited to provide qualitative feedback about the study. For the NHP-Lite study, all NHPs were included for monitoring. Community pharmacies in the Green Cross Health network were invited to participate. Participating pharmacy staff gave all NHP purchasers a study invitation card over a 2-week period (May 2016). NHP purchaser participants were emailed links to web-based baseline, follow-up and feedback questionnaires.
Results
Few community pharmacists (Ginkgo study,
n
= 3; NHP-Lite study,
n
= 18) and NHP purchasers (Ginkgo study,
n
= 0; NHP-Lite study,
n
= 4) participated. Pharmacists (Ginkgo study, 3/3; NHP-Lite study, 11/18) described several reasons for participating and suggested ways to increase consumer recruitment, including simplifying study procedures.
Conclusions
These web-based, purchase event, intensive monitoring studies, with cohorts built through NHP purchases in pharmacies, identified substantial issues with recruiting pharmacists/pharmacies and NHP purchasers that, at present, render such studies unfeasible. Future studies need to consider other methods of recruiting NHP purchasers and develop a simple method for recording NHP purchases. |
doi_str_mv | 10.1007/s40264-020-00963-y |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2491986359</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2491986359</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-b96ac375c9961403e07bf3d6a1f43172dc598776dddf003c0824c3b6495478bc3</originalsourceid><addsrcrecordid>eNp9kUFu1DAUhi0EokPhAizQk9gSsGPHidnRMtBK0zILUCU2kWM7k5TEHmwnaHY9BpyE-_QkeJgCO1Z-lr73_dL7EXpK8EuCcfkqMJxzluEcZxgLTrPdPbQgpBQZESy_jxaYEJYVgvAj9CiEa4xxlfPqITqieSF4yYsF-rmc5TDJ2DsLrgUJV6bJTmQw-gXc3nxfT1516QfL2dh4e_MDzm00NvSzgQtn--h8bzdwYWLnNLTOw7qTfpTKzf2mH6RVZq-9lHHycoAzI4fYwdo7PakYXsPKhOBsAGl1Mod-08UArXcjvDWzGdx2TLFw5fwX6C1cmm_wOSkS_Rg9aOUQzJO79xh9erf8eHqWrT68Pz99s8oULYuYNYLL_aSE4IRhanDZtFRzSVpGSZlrVYiqLLnWusWYqnQgpmjDmShYWTWKHqPnB-_Wu6-TCbG-dpO3KbLOmSCi4rQQicoPlPIuBG_aeuv7UfpdTXC976o-dFWnrurfXdW7tPTsTj01o9F_V_6UkwB6AMJ2f2Xj_2X_R_sLqimj3g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2491986359</pqid></control><display><type>article</type><title>Evaluation of a Web-Based, ‘Purchase Event’ Intensive Monitoring Method for Pharmacovigilance of Natural Health Products: Lessons and Insights from Development Work in New Zealand</title><source>SpringerLink Journals - AutoHoldings</source><creator>Barnes, Joanne ; Sheridan, Jane L. ; Dong, Christine Yang ; Härmark, Linda ; Vohra, Sunita ; Harrison-Woolrych, Mira</creator><creatorcontrib>Barnes, Joanne ; Sheridan, Jane L. ; Dong, Christine Yang ; Härmark, Linda ; Vohra, Sunita ; Harrison-Woolrych, Mira</creatorcontrib><description>Introduction
Intensive monitoring methods are used in pharmacovigilance for prescription medicines but have not yet been implemented for natural health products (NHPs).
Objectives
Our objective was to assess feasibility issues with a new ‘purchase event’ intensive monitoring method for pharmacovigilance of NHPs, including pharmacy and NHP purchaser recruitment rates, collection of NHP purchaser key patient identifier information for data linkage and quality and completeness of data.
Methods
For the Ginkgo study, 213 community pharmacies in the Auckland (Aotearoa New Zealand) District Health Board area were invited to participate. Staff in participating pharmacies (
n
= 3 [1.4%]) recorded ginkgo product sales and gave purchasers a study invitation card (October 2015–January 2016). Ginkgo purchaser participants were emailed links to web-based baseline and follow-up questionnaires about adverse events occurring during/after taking ginkgo. Participating pharmacists and consumers were invited to provide qualitative feedback about the study. For the NHP-Lite study, all NHPs were included for monitoring. Community pharmacies in the Green Cross Health network were invited to participate. Participating pharmacy staff gave all NHP purchasers a study invitation card over a 2-week period (May 2016). NHP purchaser participants were emailed links to web-based baseline, follow-up and feedback questionnaires.
Results
Few community pharmacists (Ginkgo study,
n
= 3; NHP-Lite study,
n
= 18) and NHP purchasers (Ginkgo study,
n
= 0; NHP-Lite study,
n
= 4) participated. Pharmacists (Ginkgo study, 3/3; NHP-Lite study, 11/18) described several reasons for participating and suggested ways to increase consumer recruitment, including simplifying study procedures.
Conclusions
These web-based, purchase event, intensive monitoring studies, with cohorts built through NHP purchases in pharmacies, identified substantial issues with recruiting pharmacists/pharmacies and NHP purchasers that, at present, render such studies unfeasible. Future studies need to consider other methods of recruiting NHP purchasers and develop a simple method for recording NHP purchases.</description><identifier>ISSN: 0114-5916</identifier><identifier>EISSN: 1179-1942</identifier><identifier>DOI: 10.1007/s40264-020-00963-y</identifier><identifier>PMID: 32596765</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Dietary supplements ; Drug Safety and Pharmacovigilance ; Drug stores ; Feedback ; Ginkgo ; Herbal medicine ; Medicine ; Medicine & Public Health ; Monitoring methods ; Original Research Article ; Pharmacists ; Pharmacology ; Pharmacology/Toxicology ; Pharmacovigilance ; Purchasing ; Questionnaires ; Recruitment</subject><ispartof>Drug safety, 2020-10, Vol.43 (10), p.981-998</ispartof><rights>Springer Nature Switzerland AG 2020</rights><rights>Copyright Springer Nature B.V. Oct 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-b96ac375c9961403e07bf3d6a1f43172dc598776dddf003c0824c3b6495478bc3</citedby><cites>FETCH-LOGICAL-c375t-b96ac375c9961403e07bf3d6a1f43172dc598776dddf003c0824c3b6495478bc3</cites><orcidid>0000-0002-9314-9298 ; 0000-0002-1522-8433 ; 0000-0002-0312-3095</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s40264-020-00963-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s40264-020-00963-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,778,782,27907,27908,41471,42540,51302</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32596765$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Barnes, Joanne</creatorcontrib><creatorcontrib>Sheridan, Jane L.</creatorcontrib><creatorcontrib>Dong, Christine Yang</creatorcontrib><creatorcontrib>Härmark, Linda</creatorcontrib><creatorcontrib>Vohra, Sunita</creatorcontrib><creatorcontrib>Harrison-Woolrych, Mira</creatorcontrib><title>Evaluation of a Web-Based, ‘Purchase Event’ Intensive Monitoring Method for Pharmacovigilance of Natural Health Products: Lessons and Insights from Development Work in New Zealand</title><title>Drug safety</title><addtitle>Drug Saf</addtitle><addtitle>Drug Saf</addtitle><description>Introduction
Intensive monitoring methods are used in pharmacovigilance for prescription medicines but have not yet been implemented for natural health products (NHPs).
Objectives
Our objective was to assess feasibility issues with a new ‘purchase event’ intensive monitoring method for pharmacovigilance of NHPs, including pharmacy and NHP purchaser recruitment rates, collection of NHP purchaser key patient identifier information for data linkage and quality and completeness of data.
Methods
For the Ginkgo study, 213 community pharmacies in the Auckland (Aotearoa New Zealand) District Health Board area were invited to participate. Staff in participating pharmacies (
n
= 3 [1.4%]) recorded ginkgo product sales and gave purchasers a study invitation card (October 2015–January 2016). Ginkgo purchaser participants were emailed links to web-based baseline and follow-up questionnaires about adverse events occurring during/after taking ginkgo. Participating pharmacists and consumers were invited to provide qualitative feedback about the study. For the NHP-Lite study, all NHPs were included for monitoring. Community pharmacies in the Green Cross Health network were invited to participate. Participating pharmacy staff gave all NHP purchasers a study invitation card over a 2-week period (May 2016). NHP purchaser participants were emailed links to web-based baseline, follow-up and feedback questionnaires.
Results
Few community pharmacists (Ginkgo study,
n
= 3; NHP-Lite study,
n
= 18) and NHP purchasers (Ginkgo study,
n
= 0; NHP-Lite study,
n
= 4) participated. Pharmacists (Ginkgo study, 3/3; NHP-Lite study, 11/18) described several reasons for participating and suggested ways to increase consumer recruitment, including simplifying study procedures.
Conclusions
These web-based, purchase event, intensive monitoring studies, with cohorts built through NHP purchases in pharmacies, identified substantial issues with recruiting pharmacists/pharmacies and NHP purchasers that, at present, render such studies unfeasible. Future studies need to consider other methods of recruiting NHP purchasers and develop a simple method for recording NHP purchases.</description><subject>Dietary supplements</subject><subject>Drug Safety and Pharmacovigilance</subject><subject>Drug stores</subject><subject>Feedback</subject><subject>Ginkgo</subject><subject>Herbal medicine</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Monitoring methods</subject><subject>Original Research Article</subject><subject>Pharmacists</subject><subject>Pharmacology</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacovigilance</subject><subject>Purchasing</subject><subject>Questionnaires</subject><subject>Recruitment</subject><issn>0114-5916</issn><issn>1179-1942</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kUFu1DAUhi0EokPhAizQk9gSsGPHidnRMtBK0zILUCU2kWM7k5TEHmwnaHY9BpyE-_QkeJgCO1Z-lr73_dL7EXpK8EuCcfkqMJxzluEcZxgLTrPdPbQgpBQZESy_jxaYEJYVgvAj9CiEa4xxlfPqITqieSF4yYsF-rmc5TDJ2DsLrgUJV6bJTmQw-gXc3nxfT1516QfL2dh4e_MDzm00NvSzgQtn--h8bzdwYWLnNLTOw7qTfpTKzf2mH6RVZq-9lHHycoAzI4fYwdo7PakYXsPKhOBsAGl1Mod-08UArXcjvDWzGdx2TLFw5fwX6C1cmm_wOSkS_Rg9aOUQzJO79xh9erf8eHqWrT68Pz99s8oULYuYNYLL_aSE4IRhanDZtFRzSVpGSZlrVYiqLLnWusWYqnQgpmjDmShYWTWKHqPnB-_Wu6-TCbG-dpO3KbLOmSCi4rQQicoPlPIuBG_aeuv7UfpdTXC976o-dFWnrurfXdW7tPTsTj01o9F_V_6UkwB6AMJ2f2Xj_2X_R_sLqimj3g</recordid><startdate>20201001</startdate><enddate>20201001</enddate><creator>Barnes, Joanne</creator><creator>Sheridan, Jane L.</creator><creator>Dong, Christine Yang</creator><creator>Härmark, Linda</creator><creator>Vohra, Sunita</creator><creator>Harrison-Woolrych, Mira</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>7RV</scope><scope>7T2</scope><scope>7TK</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><orcidid>https://orcid.org/0000-0002-9314-9298</orcidid><orcidid>https://orcid.org/0000-0002-1522-8433</orcidid><orcidid>https://orcid.org/0000-0002-0312-3095</orcidid></search><sort><creationdate>20201001</creationdate><title>Evaluation of a Web-Based, ‘Purchase Event’ Intensive Monitoring Method for Pharmacovigilance of Natural Health Products: Lessons and Insights from Development Work in New Zealand</title><author>Barnes, Joanne ; Sheridan, Jane L. ; Dong, Christine Yang ; Härmark, Linda ; Vohra, Sunita ; Harrison-Woolrych, Mira</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-b96ac375c9961403e07bf3d6a1f43172dc598776dddf003c0824c3b6495478bc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Dietary supplements</topic><topic>Drug Safety and Pharmacovigilance</topic><topic>Drug stores</topic><topic>Feedback</topic><topic>Ginkgo</topic><topic>Herbal medicine</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Monitoring methods</topic><topic>Original Research Article</topic><topic>Pharmacists</topic><topic>Pharmacology</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacovigilance</topic><topic>Purchasing</topic><topic>Questionnaires</topic><topic>Recruitment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Barnes, Joanne</creatorcontrib><creatorcontrib>Sheridan, Jane L.</creatorcontrib><creatorcontrib>Dong, Christine Yang</creatorcontrib><creatorcontrib>Härmark, Linda</creatorcontrib><creatorcontrib>Vohra, Sunita</creatorcontrib><creatorcontrib>Harrison-Woolrych, Mira</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Drug safety</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Barnes, Joanne</au><au>Sheridan, Jane L.</au><au>Dong, Christine Yang</au><au>Härmark, Linda</au><au>Vohra, Sunita</au><au>Harrison-Woolrych, Mira</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of a Web-Based, ‘Purchase Event’ Intensive Monitoring Method for Pharmacovigilance of Natural Health Products: Lessons and Insights from Development Work in New Zealand</atitle><jtitle>Drug safety</jtitle><stitle>Drug Saf</stitle><addtitle>Drug Saf</addtitle><date>2020-10-01</date><risdate>2020</risdate><volume>43</volume><issue>10</issue><spage>981</spage><epage>998</epage><pages>981-998</pages><issn>0114-5916</issn><eissn>1179-1942</eissn><abstract>Introduction
Intensive monitoring methods are used in pharmacovigilance for prescription medicines but have not yet been implemented for natural health products (NHPs).
Objectives
Our objective was to assess feasibility issues with a new ‘purchase event’ intensive monitoring method for pharmacovigilance of NHPs, including pharmacy and NHP purchaser recruitment rates, collection of NHP purchaser key patient identifier information for data linkage and quality and completeness of data.
Methods
For the Ginkgo study, 213 community pharmacies in the Auckland (Aotearoa New Zealand) District Health Board area were invited to participate. Staff in participating pharmacies (
n
= 3 [1.4%]) recorded ginkgo product sales and gave purchasers a study invitation card (October 2015–January 2016). Ginkgo purchaser participants were emailed links to web-based baseline and follow-up questionnaires about adverse events occurring during/after taking ginkgo. Participating pharmacists and consumers were invited to provide qualitative feedback about the study. For the NHP-Lite study, all NHPs were included for monitoring. Community pharmacies in the Green Cross Health network were invited to participate. Participating pharmacy staff gave all NHP purchasers a study invitation card over a 2-week period (May 2016). NHP purchaser participants were emailed links to web-based baseline, follow-up and feedback questionnaires.
Results
Few community pharmacists (Ginkgo study,
n
= 3; NHP-Lite study,
n
= 18) and NHP purchasers (Ginkgo study,
n
= 0; NHP-Lite study,
n
= 4) participated. Pharmacists (Ginkgo study, 3/3; NHP-Lite study, 11/18) described several reasons for participating and suggested ways to increase consumer recruitment, including simplifying study procedures.
Conclusions
These web-based, purchase event, intensive monitoring studies, with cohorts built through NHP purchases in pharmacies, identified substantial issues with recruiting pharmacists/pharmacies and NHP purchasers that, at present, render such studies unfeasible. Future studies need to consider other methods of recruiting NHP purchasers and develop a simple method for recording NHP purchases.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>32596765</pmid><doi>10.1007/s40264-020-00963-y</doi><tpages>18</tpages><orcidid>https://orcid.org/0000-0002-9314-9298</orcidid><orcidid>https://orcid.org/0000-0002-1522-8433</orcidid><orcidid>https://orcid.org/0000-0002-0312-3095</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0114-5916 |
ispartof | Drug safety, 2020-10, Vol.43 (10), p.981-998 |
issn | 0114-5916 1179-1942 |
language | eng |
recordid | cdi_proquest_journals_2491986359 |
source | SpringerLink Journals - AutoHoldings |
subjects | Dietary supplements Drug Safety and Pharmacovigilance Drug stores Feedback Ginkgo Herbal medicine Medicine Medicine & Public Health Monitoring methods Original Research Article Pharmacists Pharmacology Pharmacology/Toxicology Pharmacovigilance Purchasing Questionnaires Recruitment |
title | Evaluation of a Web-Based, ‘Purchase Event’ Intensive Monitoring Method for Pharmacovigilance of Natural Health Products: Lessons and Insights from Development Work in New Zealand |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T05%3A11%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20a%20Web-Based,%20%E2%80%98Purchase%20Event%E2%80%99%20Intensive%20Monitoring%20Method%20for%20Pharmacovigilance%20of%20Natural%20Health%20Products:%20Lessons%20and%20Insights%20from%20Development%20Work%20in%20New%20Zealand&rft.jtitle=Drug%20safety&rft.au=Barnes,%20Joanne&rft.date=2020-10-01&rft.volume=43&rft.issue=10&rft.spage=981&rft.epage=998&rft.pages=981-998&rft.issn=0114-5916&rft.eissn=1179-1942&rft_id=info:doi/10.1007/s40264-020-00963-y&rft_dat=%3Cproquest_cross%3E2491986359%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2491986359&rft_id=info:pmid/32596765&rfr_iscdi=true |